Wondfo Biotech Plans Buyback of 30-60 Million RMB; Chairman to Add 20-40 Million RMB

Wondfo Biotech, founded in 2000, announced on the evening of July 28 that it plans to repurchase shares using its own funds of no less than 30 million yuan and no more than 60 million yuan, all for implementing equity incentives or employee stock ownership plans. The repurchase price cap is 27.06 yuan per share, and the repurchase period is three months from the date of board approval. After completion, the proportion of restricted shares will rise from 8.12% to either 8.60% or 8.36%. If the shares are not granted within 36 months, unused shares will be canceled according to law. On the same day, the company's controlling shareholder and chairman, Wang Jihua, announced that he plans to increase his holdings through centralized bidding trading within three months from the announcement date, with an amount of no less than 20 million yuan and no more than 40 million yuan, without a price range. Wang Jihua directly holds 10.6% of the company's shares, and he and his spouse Li Wenmei together hold 31.5%. The increase will not result in a change of control or affect the listing conditions of the company's equity distribution.